ChartMill,,2019-05-23 14:21:00,42.822,Although the technical rating is bad RGNX does present a nice setup opportunity chartmillcomanalyzephpu
bbooystock,,2019-05-23 13:22:00,42.915,RGNX believe RGNX is in playNovartis buyer Interesting that Biogen and Regeneron would likely enter bidding too for competitive advantage
bbooystock,,2019-05-23 12:09:00,42.79,RGNX Novartis has 22 billion in cash and market cap of 220 billion RGNX has 450 million in cash and market cap of 14 billion Novartis will soon be writing a lot of royalty checks and milestone payments to RGNX
bbooystock,,2019-05-23 12:06:00,42.788,RGNX 127 a share for RGNX which would be same valuation as Roche bought ONCE Spark
bbooystock,,2019-05-23 09:56:00,42.192,RGNX Novartis to buyRGNX soon in my best opinion only my opinion just based on situation
